Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-054995
Filing Date
2013-10-23
Accepted
2013-10-23 17:22:01
Documents
1
Period of Report
2013-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd393223.html 4  
1 FORM 4 rrd393223.xml 4 3736
  Complete submission text file 0001181431-13-054995.txt   5062
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 WOOSAMONSA RD PENNINGTON NJ 08534
Business Address
Smaldone Alsup Laurie (Reporting) CIK: 0001589602 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 131166349